By ShareProphets | Sunday 15 June 2014
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Investment Case: Majority owned by Hutchison Whampoa, the Hong Kong-listed renowned multinational infrastructure, property, retail and telecommunications conglomerate including the likes of the ‘3’ mobile business, Hutchison China MediTech (HCM) is the holding company of a primarily China-based healthcare and drug development group. This includes growing businesses selling already established products and a drug research & development business which has developed strongly and looks to offer vast upside potential. This combination makes the shares a buy at an 870p offer price.
Filed under:
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Time left: 08:25:02